MannKind Corp
MNKD
$4.30
Share price
2.75%
Change (1 day)
10.41%
Change (1 year)
Categories
Operating Margin for MannKind Corp (MNKD)
Operating Margin as of April 2024 (TTM): -87.60%
According to MannKind Corp's latest financial reports and stock price the company's current Operating Margin is -87.60%. At the end of 2021 the company had an Operating Margin of -107.27%.
Operating Margin history for MannKind Corp from 2010 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -107.27% | 21.62% |
| 2020 | -88.20% | 7.12% |
| 2019 | -82.34% | -73.55% |
| 2018 | -311.34% | -68.82% |
| 2017 | -998.57% | -1488.69% |
| 2016 | 71.91% | |
| 2012 | -485,068.57% | 50.83% |
| 2011 | -321,608.00% | 75.36% |
| 2010 | -183,397.85% | |
| 2008 | -1,515,185.00% | -48.32% |
| 2007 | -2,931,870.00% | 1171.72% |
| 2006 | -230,543.00% | |
| 2001 | -14,798.47% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 34.61% | -139.51% | 🇺🇸 USA |
 Novo Nordisk NVO | 39.02% | -144.54% | 🇩🇰 Denmark |
 Eli Lilly LLY | 24.66% | -128.15% | 🇺🇸 USA |
 Merck MRK | 27.73% | -131.66% | 🇺🇸 USA |
 Halozyme Therapeutics HALO | 37.47% | -142.77% | 🇺🇸 USA |
 Nektar Therapeutics
NKTR | -396.48% | 352.60% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.